{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:27:05Z","timestamp":1790940425512,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.cca.2005.09.020","type":"journal-article","created":{"date-parts":[[2005,11,30]],"date-time":"2005-11-30T19:57:23Z","timestamp":1133380643000},"page":"68-77","source":"Crossref","is-referenced-by-count":74,"title":["Review: Collagen markers in early arthritic diseases"],"prefix":"10.1016","volume":"365","author":[{"given":"K.A.","family":"Elsaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.O.","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2005.09.020_bib1","series-title":"Methods enzymology: structural and contractile proteins, part D","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0076-6879(87)45020-9","article-title":"Cartilage","volume":"vol. 145","author":"Heing\u00e5rd","year":"1987"},{"key":"10.1016\/j.cca.2005.09.020_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/ar380","article-title":"Collagens of articular cartilage","volume":"4","author":"Eyre","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.cca.2005.09.020_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1749-6632.1985.tb51167.x","article-title":"Post-translational processing of procollagens","volume":"460","author":"Kivirikko","year":"1985","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2005.09.020_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-291X(80)90347-2","article-title":"The hydroxypyridinium crosslinks of skeletal collagens: their measurement, properties, and proposed pathway of formation","volume":"92","author":"Eyre","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2005.09.020_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0006-291X(84)80237-5","article-title":"Cartilage type IX collagen is cross-linked by hydroxypyridinium residues","volume":"123","author":"Wu","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2005.09.020_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0021-9258(18)89719-8","article-title":"The structure of type IX collagen","volume":"260","author":"Van der rest","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2005.09.020_bib7","doi-asserted-by":"crossref","first-page":"23007","DOI":"10.1016\/S0021-9258(18)50048-X","article-title":"Identification of cross-linking sites in bovine cartilage type IX collagen reveals an anti-parallel type II\u2013type IX molecular relationship and type IX to type XI bonding","volume":"267","author":"Wu","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2005.09.020_bib8","first-page":"14","article-title":"Hypothesis: can type IX collagen \u201cglue\u201d together intersecting type II fibers in articular cartilage matrix? A proposed mechanism","volume":"19","author":"Smith","year":"1992","journal-title":"J Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1988.tb14158.x","article-title":"Susceptibility of cartilage collagens type II, IX, X, and XI to human synovial collagenase and neutrophil elastase","volume":"175","author":"Gadher","year":"1988","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.cca.2005.09.020_bib10","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1172\/JCI119316","article-title":"Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage","volume":"99","author":"Billinghurst","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2005.09.020_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI118475","article-title":"Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage","volume":"97","author":"Mitchell","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2005.09.020_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-133-5-200009050-00007","article-title":"Joint injury in young adults and risk for subsequent knee and hip osteoarthritis","volume":"133","author":"Gelber","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2005.09.020_bib13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9","article-title":"Mutations in fibrillar collagens (type I, II, IIII, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels","volume":"9","author":"Kuivaniemi","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cca.2005.09.020_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/03009748709102927","article-title":"Macrophage-like cells of the pannus tissue cells in rheumatoid arthritis","volume":"16","author":"Salisbury","year":"1987","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cca.2005.09.020_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00270349","article-title":"Proliferation of pannus tissue cells in rheumatoid arthritis","volume":"6","author":"Mohr","year":"1986","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2005.09.020_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/joca.2000.0379","article-title":"An analysis of 14 molecular markers for monitoring osteoarthritis. Relationship of the markers to clinical endpoints","volume":"9","author":"Otterness","year":"2001","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.cca.2005.09.020_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/joca.1999.0288","article-title":"An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline","volume":"8","author":"Otterness","year":"2000","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.cca.2005.09.020_bib18","first-page":"697","article-title":"Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort","volume":"32","author":"Garnero","year":"2005","journal-title":"J Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib19","first-page":"28","article-title":"Markers of altered metabolism in osteoarthritis","volume":"70","author":"Lohmander","year":"2004","journal-title":"J Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib20","series-title":"Modern therapeutics in rheumatic diseases","first-page":"215","article-title":"Using molecular markers to monitor osteoarthritis","author":"Otterness","year":"2001"},{"key":"10.1016\/j.cca.2005.09.020_bib21","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/art.10586","article-title":"Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis?","volume":"46","author":"Poole","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jcb.240280104","article-title":"Enzymes converting procollagens to collagens","volume":"28","author":"Peltonen","year":"1985","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.cca.2005.09.020_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0167-4838(87)90196-8","article-title":"The carboxypropeptide trimer of type II collagen is a prominent component of immature cartilages and intervertebral-disc tissue","volume":"916","author":"Niyibizi","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2005.09.020_bib24","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI4853","article-title":"Evidence for altered synthesis of type II collagen in patients with osteoarthritis","volume":"102","author":"Nelson","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2005.09.020_bib25","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1083\/jcb.104.5.1435","article-title":"The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of type II collagen (chondrocalcin)","volume":"104","author":"Hinek","year":"1987","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cca.2005.09.020_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1063-4584(05)80027-5","article-title":"Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis","volume":"1","author":"Shinmei","year":"1993","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.cca.2005.09.020_bib27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI117753","article-title":"Cartilage and bone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism","volume":"95","author":"M\u00e5nsson","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2005.09.020_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/ard.62.1.27","article-title":"Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis","volume":"62","author":"Sugiyama","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.cca.2005.09.020_bib29","first-page":"1765","article-title":"Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after injury, and osteoarthritis","volume":"23","author":"Lohmander","year":"1996","journal-title":"J Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.56.8.500","article-title":"Synovial fluid concentrations of the C-propeptide of type II collagen correlate with body mass index in primary knee osteoarthritis","volume":"56","author":"Kobayashi","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2005.09.020_bib31","doi-asserted-by":"crossref","first-page":"10334","DOI":"10.1016\/S0021-9258(18)86950-2","article-title":"Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA","volume":"265","author":"Maureen","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2005.09.020_bib32","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1083\/jcb.114.6.1307","article-title":"Alternatively spliced type II procollagen mRNA define distinct populations of cells during vertebral development: different expression of the amino-propeptide","volume":"114","author":"Sandell","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cca.2005.09.020_bib33","first-page":"664","article-title":"Differential expression of type IIA collagen in early osteoarthritis","volume":"26","author":"Zhu","year":"2001","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/j.cca.2005.09.020_bib34","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO;2-A","article-title":"Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage","volume":"42","author":"Aigner","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/1529-0131(200104)44:4<947::AID-ANR152>3.0.CO;2-4","article-title":"Expression of sox9 and type II procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis","volume":"44","author":"Salminen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib36","first-page":"25","article-title":"Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide","volume":"101","author":"Rousseau","year":"2004","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.cca.2005.09.020_bib37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.joca.2004.02.004","article-title":"Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis","volume":"12","author":"Rousseau","year":"2004","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.cca.2005.09.020_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0022-1759(93)90141-S","article-title":"Quantitative immunoassays for type II collagen and its cyanogen bromide peptides","volume":"159","author":"Srinivas","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cca.2005.09.020_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.2042-7158.1996.tb03953.x","article-title":"Immunological detection of type II collagen degradation: use in the evaluation of anti-arthritic therapies","volume":"48","author":"Chichester","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.cca.2005.09.020_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08820139409087791","article-title":"Production of type II collagen specific monoclonal antibodies","volume":"23","author":"Srinivas","year":"1994","journal-title":"Immunol Invest"},{"key":"10.1016\/j.cca.2005.09.020_bib41","first-page":"218","article-title":"Quantification of collagen type II peptides in synovial fluid by inhibition ELISA","volume":"21","author":"Barrach","year":"1996","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/j.cca.2005.09.020_bib42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1063-4584(03)00151-1","article-title":"Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix","volume":"11","author":"Elsaid","year":"2003","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.cca.2005.09.020_bib43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1749-6632.1999.tb07736.x","article-title":"Type II collagen release from rabbit articular cartilage","volume":"878","author":"Felice","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2005.09.020_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0945-053X(99)00026-8","article-title":"Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibody","volume":"18","author":"Otterness","year":"1999","journal-title":"Matrix Biol"},{"key":"10.1016\/j.cca.2005.09.020_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-1759(00)00302-1","article-title":"Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA","volume":"247","author":"Downs","year":"2001","journal-title":"J Immunol Methods"},{"issue":"Suppl. 9","key":"10.1016\/j.cca.2005.09.020_bib46","first-page":"S258","article-title":"Urinary type II collagen neoepitopes in osteoarthritis patients is associated with disease severity","volume":"42","author":"Woodworth","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 9","key":"10.1016\/j.cca.2005.09.020_bib47","first-page":"S249","article-title":"Measurement of urinary type II collagen neoepitope levels in rheumatoid arthritis patients to assess joint status","volume":"42","author":"Saltarelli","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S8756-3282(01)00504-X","article-title":"Collagen type II c-telopeptide fragments as an index of cartilage degradation","volume":"29","author":"Christgau","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.cca.2005.09.020_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/1529-0131(200201)46:1<21::AID-ART10061>3.0.CO;2-Q","article-title":"Association of baseline levels of urinary glucosyl\u2013galactosyl\u2013pyridinoline and type II collagen c-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis","volume":"46","author":"Garnero","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib50","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/art.10616","article-title":"Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study","volume":"46","author":"Garnero","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/ard.60.6.619","article-title":"Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage","volume":"60","author":"Garnero","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2005.09.020_bib52","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.10576","article-title":"Uncoupling of type II collagen sythesis and degradation predicts progression of joint damage in patients with knee osteoarthritis","volume":"46","author":"Garnero","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/ard.62.10.939","article-title":"Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis","volume":"62","author":"Garnero","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2005.09.020_bib54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.joca.2004.11.007","article-title":"Knee cartilage defects: association with early radiographic osteoarthritis decreased cartilage volume, increased joint surface area and type II collagen breakdown","volume":"13","author":"Ding","year":"2005","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.cca.2005.09.020_bib55","first-page":"168","article-title":"The collagen II CTx degradation marker is generated by collagenase 3 and in urine reflects disease burden in knee OA patients","volume":"25","author":"Atley","year":"2000","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/j.cca.2005.09.020_bib56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.joca.2004.10.017","article-title":"Increase in degraded collagen type II in synovial fluid early in the rabbit meniscectomy model of osteoarthritis","volume":"13","author":"Lindhorst","year":"2005","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.cca.2005.09.020_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/art.20027","article-title":"Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis","volume":"50","author":"Matyas","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib58","first-page":"665","article-title":"Levels of col2CTx in knee joint lavage fluid from macques increase with age and osteoarthrosis severity","volume":"26","author":"Ham","year":"2001","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/j.cca.2005.09.020_bib59","first-page":"236","article-title":"The release of cross-linked peptides from type II collagen into joint fluid and serum is increased in osteoarthritis and after joint injury","volume":"25","author":"Lohmander","year":"2000","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/j.cca.2005.09.020_bib60","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/art.11326","article-title":"The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis","volume":"48","author":"Lohmander","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jim.2004.09.005","article-title":"The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases","volume":"294","author":"Poole","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cca.2005.09.020_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.190.4.535","article-title":"Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis","volume":"190","author":"Song","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.cca.2005.09.020_bib63","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/1529-0131(200101)44:1<120::AID-ANR16>3.0.CO;2-X","article-title":"The comparative degradation of type IX and type II collagens and proteoglycan in articular cartilage in early experimental inflammatory arthritis","volume":"44","author":"Kojima","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib64","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/1529-0131(200111)44:11<2503::AID-ART430>3.0.CO;2-P","article-title":"Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis","volume":"44","author":"Ishiguro","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib65","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI117156","article-title":"Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay","volume":"93","author":"Hollander","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2005.09.020_bib66","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","article-title":"Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases","volume":"51","author":"Farrell","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2005.09.020_bib67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/03008200109014253","article-title":"The nitrite\/collagen reaction: non-enzymatic nitration as a model system for age-related damage","volume":"42","author":"Paik","year":"2001","journal-title":"Conn Tiss Res"},{"key":"10.1016\/j.cca.2005.09.020_bib68","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.joca.2004.12.002","article-title":"New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis","volume":"13","author":"Deberg","year":"2005","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.cca.2005.09.020_bib69","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/art.20930","article-title":"Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis","volume":"52","author":"Charni","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib70","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/rheumatology\/38.4.338","article-title":"Type IX collagen immunoreactive peptides in synovial fluids from arthritis patients","volume":"38","author":"Wotton","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2005.09.020_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/8756-3282(96)00165-2","article-title":"Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidisim","volume":"19","author":"Orum","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.cca.2005.09.020_bib72","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/clinchem\/36.7.1328","article-title":"Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen","volume":"36","author":"Melkko","year":"1990","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2005.09.020_bib73","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptide in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cca.2005.09.020_bib74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00296-001-0170-y","article-title":"Correlation of bone and cartilage markers in the synovial fluid with the degree of osteoarthritis","volume":"21","author":"Schmidt-Rohlfing","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2005.09.020_bib75","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/ard.52.5.338","article-title":"Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis","volume":"52","author":"Kroger","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"suppl 9","key":"10.1016\/j.cca.2005.09.020_bib76","first-page":"S139","article-title":"Effects of ibuprofen on type II collagen C-telopeptide (uCTX-II) levels, a marker of cartilage degradation, in patients with osteoarthritis of the knee","volume":"44","author":"Delmas","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib77","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard.2003.007302","article-title":"Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis","volume":"63","author":"Gineyts","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"suppl 9","key":"10.1016\/j.cca.2005.09.020_bib78","first-page":"S376","article-title":"Short-term reduction in urinary CTX-II, a marker of cartilage degradation, predicts long-term radiological progression in patients with rheumatoid arthritis (RA) treated with disease-modifying anti-rheumatic therapy (DMARD)","volume":"46","author":"Garnero","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib79","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.20222","article-title":"Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis","volume":"50","author":"Landewe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib80","first-page":"36","article-title":"Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate","volume":"22","author":"Christgau","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cca.2005.09.020_bib81","doi-asserted-by":"crossref","first-page":"R625","DOI":"10.1186\/ar1716","article-title":"Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial","volume":"7","author":"Spector","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2005.09.020_bib82","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S8756-3282(01)00431-8","article-title":"The bisphosphonate zoledronate decrease type II collagen breakdown in patients with Paget's disease of bone","volume":"28","author":"Garnero","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.cca.2005.09.020_bib83","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.61.6.530","article-title":"Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products","volume":"61","author":"Lehmann","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2005.09.020_bib84","first-page":"499","article-title":"Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM)","volume":"11","author":"Christagu","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.cca.2005.09.020_bib85","first-page":"544","article-title":"Molecular changes in human osteoarthritic cartilage after 3 weeks of oral administration of BAY 12-9566, a matrix metalloproteinase inhibitor","volume":"30","author":"Leff","year":"2003","journal-title":"J Rheum"},{"key":"10.1016\/j.cca.2005.09.020_bib86","first-page":"896","article-title":"Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial employing biomarkers","volume":"32","author":"Cibere","year":"2005","journal-title":"J Rheum"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105005863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105005863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T19:56:26Z","timestamp":1626810986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898105005863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":86,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0009898105005863"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2005.09.020","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}